Trial Outcomes & Findings for Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon (NCT NCT01372878)
NCT ID: NCT01372878
Last Updated: 2019-08-01
Results Overview
Sensitivity and specificity of PillCam Platform with the PillCam COLON 2 capsule in detecting subjects with polyps equal to or larger than 6 mm. For a given polyp, a match between the PillCam Colon 2 Capsule and optical colonoscopy was considered if the polyp size was assessed within plus or minus 50% of the size of the estimate of the OC measurement and the polyp as appearing within the same colon segment or in adjacent segments. The polyp size measurement by optical colonoscopy was used as the reference standard. Sensitivity measures the proportion of actual positives which are correctly identified as such. Specificity measures the proportion of negatives which are correctly identified as such. positive event defined as patients with polyps ≥6 mm detected by OC procedure.
COMPLETED
NA
884 participants
1 year, same as study duration
2019-08-01
Participant Flow
Participant milestones
| Measure |
Colon Capsule Endoscopy, Then Standard Colonoscopy
Capsule endoscopy was ingested following colon preparation without colon insufflation or sedation.The purpose was to detect patients with polyps equal or larger than 6mm. Patients subsequently had standard colonoscopy as "gold standard" comparison
|
|---|---|
|
Overall Study
STARTED
|
884
|
|
Overall Study
COMPLETED
|
700
|
|
Overall Study
NOT COMPLETED
|
184
|
Reasons for withdrawal
| Measure |
Colon Capsule Endoscopy, Then Standard Colonoscopy
Capsule endoscopy was ingested following colon preparation without colon insufflation or sedation.The purpose was to detect patients with polyps equal or larger than 6mm. Patients subsequently had standard colonoscopy as "gold standard" comparison
|
|---|---|
|
Overall Study
Withdrawal by Subject
|
63
|
|
Overall Study
Protocol Violation
|
17
|
|
Overall Study
incomplete study procedure
|
104
|
Baseline Characteristics
Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
Baseline characteristics by cohort
| Measure |
Colon Capsule Endoscopy, Then Standard Colonoscopy
n=884 Participants
Capsule endoscopy was ingested following colon preparation without colon insufflation or sedation.The purpose was to detect patients with polyps equal or larger than 6mm. Patients subsequently had standard colonoscopy as "gold standard" comparison
|
|---|---|
|
Age, Continuous
|
57.29 years
STANDARD_DEVIATION 5.84 • n=113 Participants
|
|
Sex: Female, Male
Female
|
487 Participants
n=113 Participants
|
|
Sex: Female, Male
Male
|
397 Participants
n=113 Participants
|
|
Region of Enrollment
United States
|
558 participants
n=113 Participants
|
|
Region of Enrollment
Israel
|
326 participants
n=113 Participants
|
PRIMARY outcome
Timeframe: 1 year, same as study durationSensitivity and specificity of PillCam Platform with the PillCam COLON 2 capsule in detecting subjects with polyps equal to or larger than 6 mm. For a given polyp, a match between the PillCam Colon 2 Capsule and optical colonoscopy was considered if the polyp size was assessed within plus or minus 50% of the size of the estimate of the OC measurement and the polyp as appearing within the same colon segment or in adjacent segments. The polyp size measurement by optical colonoscopy was used as the reference standard. Sensitivity measures the proportion of actual positives which are correctly identified as such. Specificity measures the proportion of negatives which are correctly identified as such. positive event defined as patients with polyps ≥6 mm detected by OC procedure.
Outcome measures
| Measure |
Colon Capsule Endoscopy, Then Standard Colonoscopy
n=700 Participants
Capsule endoscopy was ingested following colon preparation without colon insufflation or sedation.The purpose was to detect patients with polyps equal or larger than 6mm. Patients subsequently had standard colonoscopy as "gold standard" comparison
|
|---|---|
|
Sensitivity and Specificity of PillCam Platform With the PillCam COLON 2 Capsule in Detecting Patients With Polyps ≥6 mm Where OC Considered as the Gold Standard Reference
sensitivity of patients with Polyp>= 6 mm
|
69 percentage of participants
Interval 63.0 to 74.0
|
|
Sensitivity and Specificity of PillCam Platform With the PillCam COLON 2 Capsule in Detecting Patients With Polyps ≥6 mm Where OC Considered as the Gold Standard Reference
specificty of patients with Polyp>= 6 mm
|
87 percentage of participants
Interval 85.0 to 89.0
|
SECONDARY outcome
Timeframe: 1 year, same as study durationSensitivity and specificity of PillCam Platform with the PillCam COLON 2 capsule in detecting subjects with polyps equal to or larger than 6 mm. For a given polyp, a match between the PillCam Colon 2 Capsule and optical colonoscopy was considered if the polyp size was assessed within plus or minus 50% of the size of the estimate of the OC measurement and the polyp as appearing within the same colon segment or in adjacent segments. The polyp size measurement by optical colonoscopy was used as the reference standard.
Outcome measures
| Measure |
Colon Capsule Endoscopy, Then Standard Colonoscopy
n=700 Participants
Capsule endoscopy was ingested following colon preparation without colon insufflation or sedation.The purpose was to detect patients with polyps equal or larger than 6mm. Patients subsequently had standard colonoscopy as "gold standard" comparison
|
|---|---|
|
Sensitivity and Specificity of PillCam Platform With the PillCam COLON 2 Capsule in Detecting Patients With Polyps ≥10 mm Where OC Considered as the Gold Standard Reference
sensitivity of patients with Polyp>= 10 mm
|
64 percentage of participants
Interval 55.0 to 73.0
|
|
Sensitivity and Specificity of PillCam Platform With the PillCam COLON 2 Capsule in Detecting Patients With Polyps ≥10 mm Where OC Considered as the Gold Standard Reference
specificity of patients with Polyp>= 10 mm
|
95 percentage of participants
Interval 94.0 to 96.0
|
Adverse Events
Colon Capsule Endoscopy, Then Standard Colonoscopy
Serious adverse events
| Measure |
Colon Capsule Endoscopy, Then Standard Colonoscopy
n=884 participants at risk
Capsule endoscopy was ingested following colon preparation without colon insufflation or sedation.The purpose was to detect patients with polyps equal or larger than 6mm. Patients subsequently had standard colonoscopy as "gold standard" comparison
|
|---|---|
|
Gastrointestinal disorders
abdominal pain related to OC procedure
|
0.11%
1/884 • Number of events 1
|
Other adverse events
| Measure |
Colon Capsule Endoscopy, Then Standard Colonoscopy
n=884 participants at risk
Capsule endoscopy was ingested following colon preparation without colon insufflation or sedation.The purpose was to detect patients with polyps equal or larger than 6mm. Patients subsequently had standard colonoscopy as "gold standard" comparison
|
|---|---|
|
Gastrointestinal disorders
Adverse event related to preperation
|
11.4%
101/884 • Number of events 128
|
|
Gastrointestinal disorders
Adverse event related to Capsule endoscopy
|
0.34%
3/884 • Number of events 3
|
|
Gastrointestinal disorders
Adverse event related to Colonoscopy
|
0.68%
6/884 • Number of events 11
|
Additional Information
Ravit Peled | Biostatistics and Data Management Manager
Given Imaging
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place